Related references
Note: Only part of the references are listed.Charge variants characterization and release assay development for co-formulated antibodies as a combination therapy
Mingyan Cao et al.
MABS (2019)
Antibodies to watch in 2018
Helene Kaplon et al.
MABS (2018)
DRUG PAIRING Combinations on trial
Charles Schmidt
NATURE (2017)
Combination immunotherapy: a road map
Patrick A. Ott et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2017)
Determination of critical quality attributes for monoclonal antibodies using quality by design principles
Nadja Alt et al.
BIOLOGICALS (2016)
Evaluation of the structural, physicochemical, and biological characteristics of SB4, a biosimilar of etanercept
Ick Hyun Cho et al.
MABS (2016)
Technical Decision-Making with Higher Order Structure Data: Detecting Reversible Concentration-Dependent Self-Association in a Monoclonal Antibody and a Preliminary Investigation to Eliminate It
Julie Y. Wei et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Investigation of the Physico-Chemical Properties that Enable Co-Formulation of Basal Insulin Degludec with Fast-Acting Insulin Aspart
Svend Havelund et al.
PHARMACEUTICAL RESEARCH (2015)
Separation of mAbs molecular variants by analytical hydrophobic interaction chromatography HPLC Overview and applications
Mark Haverick et al.
MABS (2014)
Compatibility and stability of pertuzumab and trastuzumab admixtures in i.v. infusion bags for coadministration
Zephania W. Kwong Glover et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
A Systematic Multitechnique Approach for Detection and Characterization of Reversible Self-Association during Formulation Development of Therapeutic Antibodies
Reza Esfandiary et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Recombinant antibody mixtures: Production strategies and cost considerations
Soren K. Rasmussen et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2012)
Rational identification of an optimal antibody mixture for targeting the epidermal growth factor receptor
Klaus Koefoed et al.
MABS (2011)
CLEOPATRA: A Phase III Evaluation of Pertuzumab and Trastuzumab for HER2-Positive Metastatic Breast Cancer
Jose Baselga et al.
CLINICAL BREAST CANCER (2010)
On the analysis of protein self-association by sedimentation velocity analytical ultracentrifugation
P Schuck
ANALYTICAL BIOCHEMISTRY (2003)
Share Paper
